EU Common Standard for electronic Pproduct Information
Ireland’s HPRA - Guidance update on Submitting Mock-ups for Labels and Leaflets
US FDA CDER Guidance Agenda -Calendar Year 2022
USFDA - Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs
Guidance for Clinical Trials Conducted under the Clinical Trials Regulation (CTR) in Ireland
Revision of PIC/S GMP Guide
USFDA Guidance on Premarket Review of Combination Products
Swissmedic Guidance on Renewals, Variations & Extensions
Ireland's guidance on New Application & Variations, Registartion Requirements,
Guidance on Revising ANDA Labeling Following Revision of the RLD Labeling
USFDA Guidance update on Generic Drug Application Submissions, Labeling, and Review
Electronic Application Form and Cover Letter Tool - UK MHRA
CHINA’S NMPA: Development Guideline of Drug-Device Combinations
India's National Pharmaceutical Pricing Authority (NPPA) -Study on global drug pricing policies
EMA Guidance for Applicants seeking Scientific Advice and Protocol Assistance
UK Guidance on Clinical Trials: How to Apply for Authorization
Guidelines for Biowaiver -Saudi Food & Drug Authority SFDA
First Oral Antiviral (PFIZER) for Treatment of COVID-19 -USFDA
Updated Guidance for Priority Review ofProduct Registration - Saudi Food & Drug Authority
Updated Guidance on Innovative Licensing and Access Pathway - MHRA